Zura Bio Limited

ZURA | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.50

$0 (0.00%)

Sep 22, 2026, 12:48 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Aug 22, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $427.58M

1D Range

4.45 4.62

52W Range

2.01 7.44

Valuation (TTM)

PE -3.98

PB 2.17

EV/EBITDA -2.59

Valuation (NTM)

Forward PE N/A

Forward PEG 0.44

Price Target $20

Cash Flow

FCF Yield -18.2%

SBC Adj. FCF Yield -21.0%

SBC Impact -15.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -34.5% | -6.5%

FCF 3Y | 5Y -53.3% | N/A

Returns

ROA -40.2%

ROE -55.0%

ROIC -47.0%

Financial Health

Net Cash

$205.13M

Current Ratio 12.90

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its ke...

Sector Healthcare

Industry Biotechnology

Employees 40

IPO Date Mar 20, 2023

Website zurabio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$20

Upside

+344.44%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞